Ischemia-modified albumin levels in maternal blood complicated by fetal distress

Aim: Identifying patients with FD during the prenatal period or during delivery will help us intervene early. Therefore, we aimed at evaluating the maternal IMA status in pregnancies complicated by FD and comparing the results with those of healthy pregnancies. Materials and Methods: One hundred and twenty patients beyond the 34th week of pregnancy were included in the study, and they were divided into two groups. Group 1 (study group) included 60 patients who were diagnosed with fetal distress had to have a cesarean section due to the Fetal distress indication according to the NST; group 2 (control group) comprised 60 patients who showed no signs of Fetal distress or any other disease and had an elective C/S due to previous C/S. Results: There was no significant difference between the groups in terms of BMI, birth weight, maternal age, gravidity and parity. IMA concentrations were found to be lower in group 2 patients compared with group 1 patients (p < 0.001). Conclusion: Increased maternal IMA levels in the intrauterine fetal distress justify the need for maternal follow-up with IMA. Although studies on the value of IMA are still few in its use in perinatology practice, we think that more studies should be done in this field

PDF

___

1. Freeman RK. Problems with intrapartum fetal heart ratemonitoring interpretation and patient management. Obstet Gynecol 2002;100:813–826.
2. Westgate JA, Wibbens B, Bennet L,Wassink G, Parer JT, Gunn AJ. Theintrapartum deceleration in center stage: a physiologic approach to the interpretation of fetal heart rate changes in labor. Am J Obstet Gynecol 2007;197:236.e1–236.11
3. Fait V, Sela S, Ophir E, et al. Peripheral polymorphonuclear leukocyte priming contributes to oxidative stress in early pregnancy. J Soc Gynecol Investig. 2005;12:46–49.
4. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological function and human diseases. Int J Biochem Cell Biol. 2007;39:44–84.
5. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “Ischemia modified albumin”, a new biochemical marker of myocardial ischaemia,in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21:29–34.
6. Electronic fetal heart rate monitoring: research guidelines for interpretation. National Institute of Child Health and Human Development Research Planning Workshop. Am J Obstet Gynecol 1997;177:1385–1390.
7. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischaemia – A preliminary report. J Emerg Med 2000;19:311–315.
8. da Silva S, Hennebert N, Denis R, Wayenberg JL. Clinical value of asingle postnatal lactate measurement after intrapartum asphyxia. Acta Paediatr 2000;89:320–323.
9. Rajakumar PS, Bhat BV, Sridhar MG, Balachander J, Konar BC, Narayanan P, Chetan G. Cardiac enzyme levels in myocardial dysfunction in newborns with perinatal asphyxia. Indian J Pediatr 2008;75:1223–1225.
10. Caglar GS, Tasci Y, Goktolga U, Oztas E, Pabuccu R, Ozdemir ED, Seker RMaternal and umbilical cord ischemia-modified albumin levels in nonreassuring fetal heart rate tracings regarding the mode of delivery.The Journal of Maternal-Fetal and Neonatal Medicine, 2013; 26(5): 528–531
11. Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–160
12. Omür D, Hacivelioglu SÖ, Oguzalp H, Uyan B, Kiraz HA, Duman C, et al. The effect of anaesthesia technique on maternal and cord blood ischaemia modified albumin levels during caesarean section: a randomized controlled study. J Int Med Res 2013;41(4):1111–9
13. Caglar GS, Erdogdu P, Gursoy AY, Seker R, Demirtas S. The impact of route of anesthesia on maternal and fetal ischemia modified albümin levels at cesarean section: a prospective randomized study. J Perinat Med 2013;41(5):573–9.
14. Kim JS, Hwang HJ, Ko YG, et al. Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice? Cardiology 2010;116: 123-129,